The KomIT core lab facility was recently opened and now provides a unique setting of state-of-the-art equipment for cellular and molecular research on the development of novel anti-diabetic therapies. In addition to modern cell culture equipment, the core lab has established a cell imaging multi-mode reader that combines automated digital microscopy and conventional microplate detection in a configurable, upgradable platform. Early next year, a fully-automated slide scanner will be established, allowing an unprecedented level of analysis for the development of novel pharmacological strategies to combat diabetes.